|
TIFA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.539200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.727000E-01 |
| Normal-vs-Stage2 |
3.384100E-02 |
| Normal-vs-Stage3 |
5.579400E-01 |
| Normal-vs-Stage4 |
4.819600E-02 |
| Stage1-vs-Stage2 |
9.143700E-02 |
| Stage1-vs-Stage3 |
9.108800E-01 |
| Stage1-vs-Stage4 |
7.619600E-02 |
| Stage2-vs-Stage3 |
1.223600E-01 |
| Stage2-vs-Stage4 |
5.826200E-01 |
| Stage3-vs-Stage4 |
1.158830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.208800E-01 |
| Normal-vs-AfricanAmerican |
1.127830E-01 |
| Normal-vs-Asian |
8.867800E-01 |
| Caucasian-vs-AfricanAmerican |
1.508850E-01 |
| Caucasian-vs-Asian |
8.170800E-01 |
| AfricanAmerican-vs-Asian |
5.028600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.895800E-01 |
| Normal-vs-Female |
9.136200E-02 |
| Male-vs-Female |
1.357030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.422400E-01 |
| Normal-vs-Extreme_Weight |
5.366800E-01 |
| Normal-vs-Obese |
1.318820E-01 |
| Normal-vs-Extreme_Obese |
4.521800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.616200E-01 |
| Normal_Weight-vs-Obese |
1.129570E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.121800E-01 |
| Extreme_Weight-vs-Obese |
1.615780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.777400E-01 |
| Obese-vs-Extreme_Obese |
7.537000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.367220E-01 |
| Normal-vs-Age(41-60Yrs) |
7.654300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.770200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.408000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.318400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.637600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.971700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.039900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.248500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.745200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.302800E-01 |
| Normal-VS-Type2 PRCC |
5.052800E-01 |
| Normal-VS-KIRP CIMP |
2.980800E-03 |
| Normal-VS-Unclassified PRCC |
6.109700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.844900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.231590E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.362600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.40689999999799E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.002900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.048960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.401800E-01 |
| Normal-vs-N1 |
9.626400E-02 |
| Normal-vs-N2 |
2.029000E-01 |
| N0-vs-N1 |
2.387600E-02 |
| N0-vs-N2 |
1.056960E-01 |
| N1-vs-N2 |
6.734400E-01 |
|
|
